Table 1.

Patient characteristics of screened cohort (n = 512 screened patients), overall and stratified by last known survival status

CharacteristicAnalysis Cohort (n = 512)Died (n = 123)Alive (n = 389)
Age (yr; mean ± SD)61 ± 1771 ± 1358 ± 17
Male gender (% [n/N])55.9 (285/510)56.1 (69/123)55.8 (216/387)
Race, ethnicity (% [n/N])
    white (versus nonwhite)65.8 (327/497)70.6 (84/119)64.3 (243/378)
    black (versus nonblack)27.2 (135/497)21.8 (26/119)28.8 (109/378)
    Hispanic (versus non-Hispanic)14.7 (73/497)13.4 (16/119)15.1 (57/378)
Time on HD (mo)n = 435n = 106n = 329
    median (q1 to q3)19 (4 to 39)21 (5 to 43)8 (4 to 37)
    <3 mo (% [n])20.2 (88)17.9 (19)21.0 (69)
Amputation (% [n/N])9.0 (40/442)8.3 (9/108)9.3 (31/334)
ESRD cause (% [n])n = 504n = 120n = 384
    other45.2 (228)48.3 (58)44.3 (170)
    diabetic (type 2) nephropathy27.2 (137)27.5 (33)27.1 (104)
    hypertensive nephropathy16.3 (82)19.2 (23)15.4 (59)
    glomerulonephritis5.8 (29)2.5 (3)6.8 (26)
    PKD adult onset (autosomal dominant)3.0 (15)0.8 (1)3.6 (14)
    diabetic (type 1) nephropathy2.6 (13)1.7 (2)2.9 (11)
  • q1 to q3, interquartile range; PKD, polycystic kidney disease.